Claris Lifesciences Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 17	Mar ' 16	Mar ' 15	Dec ' 13	Dec ' 12

Profit before tax

7.39

39.29

107.22

103.21

106.28

Net cashflow-operating activity

-

-

48.58

121.96

247.75

Net cash used in investing activity

-

-

233.97

217.22

-340.98

Netcash used in fin. activity

-

-

-329.78

-342.78

51.12

Net inc/dec in cash and equivlnt

-23.04

24.10

-47.23

-3.60

-42.11

Cash and equivalnt begin of year

45.20

21.10

68.33

71.93

114.04

Cash and equivalnt end of year

22.16

45.20

21.10

68.33

71.93